Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
PCL Hyaluronic Acid Filler
Ingredient: Polycaprolactone 10%, Cross linked hyaluronic acid 24mg/ml
Specification: 1ml
Package: Single package
Application Area: Used for nose, jaw, lacrimal groove, temple, outer contour and other subcutaneous deep or shallow injection.
Product Introduction：
Our formulation has a higher elastic modulus, ensuring exceptional viscoelasticity and superior shaping ability, with minimal risk of shifting after injection. The HA content is higher and more diverse, allowing for customized solutions tailored to different injection sites and treatment objectives for a naturally refined look. Its extended durability is influenced by the type of microspheres used, with PCL microspheres ensuring a longer-lasting effect than block copolymer microspheres. This product is effective for contouring the nose, jawline, tear troughs, temples, and beyond.
Product Display：
Product Details:
Type | PCL-HA Filler |
Ingredient | Polycaprolactone 10%, Cross linked hyaluronic acid 24mg/ml |
Specification | 1ml |
Effect area | The deep dermis, superficial subcutaneous and deep layers were filled by injection |
Application area | Used for nose, jaw, lacrimal groove, temple, outer contour and other subcutaneous deep or shallow injection |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Single package |
Storage | Cool, dry environment |
Recommended | 1-2 pc/time |
Recommended interval | 12 months |
Lasting time | 12 months |
Microsphere size | The median particle size was 32±6μm, and more than 95% of the microspheres were between 25 and 50μm |
Product Package:
Customer Feedback：
Raw Material Advantages：
With a significantly reduced injection force of 12N compared to the standard 20N, this formulation ensures a seamless and efficient application, making procedures quicker and more comfortable for both doctors and patients. Its high viscoelasticity allows for effective improvements in the nasal base, brow ridge, and outer facial contour. The HA content ranges from 20-24 mg/g, providing a broad selection and customizable options. The degradation process is influenced by the microsphere type, with PCL microspheres maintaining effects longer than block copolymer microspheres. This versatile product is suitable for treating the nose, jawline, tear troughs, temples, and more.
Development Process:
Company Introduction:
With over 15 years of experience in modifying and crosslinking polysaccharide materials, our medical-grade material modification platform enables the development of carboxymethyl chitosan from chitosan (featured in an approved anti-adhesion surgical solution) and crosslinked sodium hyaluronate using proprietary biphasic, monophasic, and micro-crosslinking processes. Our expertise extends to the preparation of medical-grade microspheres, including crosslinked starch microspheres (commercially available as a microporous polysaccharide hemostatic powder), solvent-free injectable PCL, emulsification-based injectable PLLA, and high-precision injectable PMMA microspheres.
